HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations.

Abstract
To investigate the recently reported associations of polymorphisms in lymphotoxin-alpha (LTA) and galectin-2 (LGALS2) with myocardial infarction (MI), we analyzed a single nucleotide polymorphism of LTA (LTA 252A>G in LTA intron 1) and that of LGALS2 (LGALS2 3279C>T in LGALS2 intron 1) in Japanese and Korean populations. Although significant associations with MI were not observed in either population, we found that LTA 252GG was significantly associated with the severity of the disease for both the Japanese and Korean populations (P=0.017 and P=0.001, respectively). On the other hand, the polymorphism of LGALS2 was not associated with the severity of coronary atherosclerosis. These observations showed that, while the LTA 252GG genotype might modify the development of coronary atherosclerosis, the relation of LTA and LGALS2 to MI itself remained much less certain.
AuthorsA Kimura, M Takahashi, B Y Choi, S W Bae, S Hohta, T Sasaoka, K-i Nakahara, K Chida, M Sawabe, M Yasunami, T Naruse, T Izumi, J-E Park
JournalTissue antigens (Tissue Antigens) Vol. 69 Issue 3 Pg. 265-9 (Mar 2007) ISSN: 0001-2815 [Print] England
PMID17493152 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Galectin 2
  • LGALS2 protein, human
  • Lymphotoxin-alpha
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Asian People
  • Coronary Artery Disease (genetics)
  • Female
  • Galectin 2 (genetics)
  • Humans
  • Japan
  • Korea
  • Lymphotoxin-alpha (genetics)
  • Male
  • Middle Aged
  • Myocardial Infarction (genetics)
  • Polymorphism, Single Nucleotide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: